Interleukin-6 as an Early Predictor for One-Year Survival following an Ischaemic Stroke/Transient Ischaemic Attack
- 1 February 2010
- journal article
- Published by SAGE Publications in International Journal of Stroke
- Vol. 5 (1), 16-20
- https://doi.org/10.1111/j.1747-4949.2009.00396.x
Abstract
Background: Early biomarkers for survival in an acute ischaemic stroke/transient ischaemic attack might serve as a useful tool for the clinician. Several studies have highlighted the role of inflammatory biomarkers as an early signal for acute ischaemic stroke prognosis. Aims: This study examines the potential advantage of using high-sensitivity interleukin-6 as a possible biomarker at the early stages of acute stroke for identifying patients at a high risk for 12-month mortality. Methods: Inflammatory biomarkers and neurological scores were determined in 250 patients following mild to moderate acute ischaemic stroke within 24 h of hospital admission. Outcome data on mortality were collected after 12 months. The signal detection methodology was used to identify subgroups that were at a high risk for 12-month mortality. Results: Twelve months following the event, 234 of the 250 stroke patients survived. Signal detection identified predictors that distinguished individuals likely to die from those with a better recovery prediction. Plasma interleukin-6 concentration emerged as the optimal predictor, with a cut point of 6·47pg/ml, χ2 (I, N = 250) = 20·5, P<0·001. Interleukin-6 above 6·47 pg/ml during the acute phase predicted subsequent non-survival ( P = 0·006, odds ratio 8·0). Conclusions: This study demonstrates the clinical potential of using high-sensitivity interleukin-6 as an early signal for acute ischaemic stroke survival and suggests a clear cut point for patients at a high risk who might benefit from closer clinical surveillance and/or administration of therapeutic interventions.Keywords
This publication has 15 references indexed in Scilit:
- Early signaling of inflammation in acute ischemic stroke: Clinical and rheological implicationsThrombosis Research, 2008
- Usefulness of inflammatory and haemostatic markers to predict short-term risk for death in middle-aged ischaemic stroke patientsActa Neurologica Scandinavica, 2007
- Evaluation of C-Reactive Protein Measurement for Assessing the Risk and Prognosis in Ischemic StrokeStroke, 2005
- Peak plasma interleukin-6 and other peripheral markers of inflammation in the first week of ischaemic stroke correlate with brain infarct volume, stroke severity and long-term outcomeBMC Neurology, 2004
- Levels of Anti-Inflammatory Cytokines and Neurological Worsening in Acute Ischemic StrokeStroke, 2003
- Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)Jama-Journal Of The American Medical Association, 2001
- Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment.Stroke, 1993
- Who will relapse? Symptoms of nicotine dependence predict long-term relapse after smoking cessation.Journal of Consulting and Clinical Psychology, 1992
- Recommendation for Measurement of Erythrocyte Sedimentation Rate of Human Blood: International Committee For Standardization in HaematologyAmerican Journal of Clinical Pathology, 1977
- Gerinnungsphysiologische Schnellmethode zur Bestimmung des FibrinogensActa Haematologica, 1957